organization · Reporting owner
EW Healthcare Partners Fund 2 GP, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TELA Bio, Inc.TELA · Entity 7381 | 10% owner · See Remarks | November 17, 2025 | November 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TELA Bio, Inc.
Report date November 17, 2025 · Filed November 17, 2025
Jointly reported with EW HEALTHCARE PARTNERS FUND 2, L.P., EW HEALTHCARE PARTNERS FUND 2-A, L.P., EW Healthcare Partners Fund 2-UGP, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | Direct | 7,714,709 |
Reported balance
After 2025-11-17 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-11-17 · Purchase · Acquired 3,604,000 · Balance 7,714,709 F1: Shares of the Issuer's common stock acquired in the Issuer's underwritten registered direct offering at a price of $1.11 per share. Consists of 1,416,249 shares acquired by EW Healthcare Partners Fund 2, L.P. and 2,187,751 shares acquired by EW Healthcare Partners Fund 2-A, L.P. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of the Issuer's common stock acquired in the Issuer's underwritten registered direct offering at a price of $1.11 per share. Consists of 1,416,249 shares acquired by EW Healthcare Partners Fund 2, L.P. and 2,187,751 shares acquired by EW Healthcare Partners Fund 2-A, L.P.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 23, 2021 Filed Nov 23, 2021 17:40 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 516 | $12.49 | $6,444.84 |
DisclosureSEC source: 0000899243-21-045832 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,851,990 F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,295 and 203 shares of the amounts shown above for November 22 and November 23, respectively, and Fund 2-A purchased 2,000 and 313 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 769,552 shares and Fund 2-A now holds a total of 1,082,438 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 17:40 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 3,295 | $12.49 | $41,154.55 |
DisclosureSEC source: 0000899243-21-045832 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,851,474 F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,295 and 203 shares of the amounts shown above for November 22 and November 23, respectively, and Fund 2-A purchased 2,000 and 313 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 769,552 shares and Fund 2-A now holds a total of 1,082,438 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 18:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 4,419 | $12.41 | $54,839.79 |
DisclosureSEC source: 0000899243-21-045426 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,848,179 F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 393 and 1,737 shares of the amounts shown above for November 17th and November 18th, respectively, and Fund 2-A purchased 607 and 2,682 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 768,054 shares and Fund 2-A now holds a total of 1,080,125 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 18:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 1,000 | $12.50 | $12,500.00 |
DisclosureSEC source: 0000899243-21-045426 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,843,760 F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 393 and 1,737 shares of the amounts shown above for November 17th and November 18th, respectively, and Fund 2-A purchased 607 and 2,682 shares of the amounts shown above on each such date, respectively. Fund 2 now holds a total of 768,054 shares and Fund 2-A now holds a total of 1,080,125 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 19:18 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 1,000 | $12.50 | $12,500.00 |
DisclosureSEC source: 0000899243-21-044468 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,842,760 F1 · ownership.nature: The Share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 393 shares of the amount shown above and Fund 2-A purchased 607 shares of the amount shown above. Fund 2 now holds a total of 765,924 shares and Fund 2-A now holds a total of 1,076,836 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| October 27, 2021 Filed Oct 29, 2021 16:13 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 5,088 | $12.43 | $63,243.84 |
DisclosureSEC source: 0000899243-21-042025 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,841,760 F1 · ownership.nature: The Share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 1,999 shares of the amount shown above and Fund 2-A purchased 3,089 shares of the amount shown above. Fund 2 now holds a total of 765,531 shares and Fund 2-A now holds a total of 1,076,229 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 17:40 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 2,090 | $12.42 | $25,957.80 |
DisclosureSEC source: 0000899243-21-041319 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,836,672 F1 · ownership.nature: The Share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 1,736 shares of the amount shown above and Fund 2-A purchased 354 shares of the amount shown above. Fund 2 now holds a total of 763,532 shares and Fund 2-A now holds a total of 1,073,140 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| October 13, 2021 Filed Oct 13, 2021 18:20 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 200 | $12.50 | $2,500.00 |
DisclosureSEC source: 0000899243-21-040139 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,834,582 F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2-A purchased all of the shares of the amounts shown above. Fund 2 now holds a total of 761,796 shares and Fund 2-A now holds a total of 1,072,786 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 18:20 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 283 | $12.50 | $3,537.50 |
DisclosureSEC source: 0000899243-21-040139 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,834,382 F1 · ownership.nature: The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2-A purchased all of the shares of the amounts shown above. Fund 2 now holds a total of 761,796 shares and Fund 2-A now holds a total of 1,072,786 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| October 06, 2021 Filed Oct 8, 2021 12:57 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 110 | $12.50 | $1,375.00 |
DisclosureSEC source: 0000899243-21-039655 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,834,099 F1 · ownership.nature: The Share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2-A purchased all of the shares of the amount shown above. Fund 2 now holds a total of 761,796 shares and Fund 2-A now holds a total of 1,072,303 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 21, 2021 Filed Sep 23, 2021 18:38 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 695 | $12.60 | $8,757.00 |
DisclosureSEC source: 0000899243-21-037386 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,833,989 F1 · ownership.nature: The Share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 273 shares of the amount shown above and Fund 2-A purchased 422 shares of such aggregate amount. Fund 2 now holds a total of 761,796 shares and Fund 2-A now holds a total of 1,072,193 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 17:41 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 924 | $12.58 | $11,623.92 |
DisclosureSEC source: 0000899243-21-036805 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,833,294 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 363 shares of the amount shown above on September 20, 2021, and Fund 2-A purchased 322 shares and 561 shares of the amounts shown above for September 17 and September 20, 2021, respectively. Fund 2 now holds a total of 761,523 shares and Fund 2-A now holds a total of 1,071,771 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 17:41 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 322 | $12.61 | $4,060.42 |
DisclosureSEC source: 0000899243-21-036805 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,832,370 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 363 shares of the amount shown above on September 20, 2021, and Fund 2-A purchased 322 shares and 561 shares of the amounts shown above for September 17 and September 20, 2021, respectively. Fund 2 now holds a total of 761,523 shares and Fund 2-A now holds a total of 1,071,771 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 15, 2021 Filed Sep 20, 2021 18:31 UTC Amendment | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 10,000 | $12.43 | $124,300.00 |
DisclosureSEC source: 0000899243-21-036633 · doc4a.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,832,048 F3 · date: This Amended Form 4 is filed only to correct the date set forth in the original Form 4 filed on September 17, 2021. No other change has been made to the original Form 4 filed on September 17, 2021 relating to the trade made on September 15, 2021. F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 4,045 shares of the amount shown above and Fund 2-A purchased 5,955 shares of the amount shown above. Fund 2 now holds a total of 761,160 shares and Fund 2-A now holds a total of 1,070,888 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 13:23 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 10,000 | $12.27 | $122,700.00 |
DisclosureSEC source: 0000899243-21-036056 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,822,048 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 3,930 shares of the amount shown above on September 14, and Fund 2-A purchased 115 shares and 6,070 shares of the amounts shown above on September 13 and 14, respectively. Fund 2 now holds a total of 757,115 shares and Fund 2-A now holds a total of 1,064,933 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 13:23 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 115 | $12.43 | $1,429.45 |
DisclosureSEC source: 0000899243-21-036056 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,812,048 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 3,930 shares of the amount shown above on September 14, and Fund 2-A purchased 115 shares and 6,070 shares of the amounts shown above on September 13 and 14, respectively. Fund 2 now holds a total of 757,115 shares and Fund 2-A now holds a total of 1,064,933 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 13, 2021 Filed Sep 17, 2021 16:52 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 10,000 | $12.43 | $124,300.00 |
DisclosureSEC source: 0000899243-21-036434 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,832,048 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 4,045 shares of the amount shown above and Fund 2-A purchased 5,955 shares of the amount shown above. Fund 2 now holds a total of 761,160 shares and Fund 2-A now holds a total of 1,070,888 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 14:55 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 14,436 | $12.31 | $177,707.16 |
DisclosureSEC source: 0000899243-21-035636 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,811,933 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 5,321 shares and 5,673 shares of the amount shown above on September 9 and 10, respectively, and Fund 2-A purchased 7,766 shares and 8,763 shares of the amount shown above on September 9 and 10, respectively. Fund 2 now holds a total of 753,185 shares and Fund 2-A now holds a total of 1,058,748 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 14:55 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 13,087 | $12.46 | $163,064.02 |
DisclosureSEC source: 0000899243-21-035636 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,797,497 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 5,321 shares and 5,673 shares of the amount shown above on September 9 and 10, respectively, and Fund 2-A purchased 7,766 shares and 8,763 shares of the amount shown above on September 9 and 10, respectively. Fund 2 now holds a total of 753,185 shares and Fund 2-A now holds a total of 1,058,748 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 13:36 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 47 | $13.24 | $622.28 |
DisclosureSEC source: 0000899243-21-035395 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,784,410 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2-A purchased all of the shares of the amounts shown purchased. Fund 2 now holds a total of 742,191 shares and Fund 2-A now holds a total of 1,042,219 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds 89,515GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 13:36 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 131 | $12.77 | $1,672.87 |
DisclosureSEC source: 0000899243-21-035395 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,784,363 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2-A purchased all of the shares of the amounts shown purchased. Fund 2 now holds a total of 742,191 shares and Fund 2-A now holds a total of 1,042,219 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds 89,515GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 12:17 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 79,970 | $12.50 | $999,625.00 |
DisclosureSEC source: 0000899243-21-024092 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,784,232 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 48,545 shares and Fund 2-A purchased 31,425 shares of the amount shown purchased. Fund 2 now holds a total of 742,191 shares and Fund 2-A now holds a total of 1,042,041 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds 89,515GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:20 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 10,000 | $12.99 | $129,900.00 |
DisclosureSEC source: 0000899243-21-022886 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,704,262 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 4,131 shares and Fund 2-A purchased 5,869 shares of the amount shown purchased. Fund 2 now holds a total of 693,646 shares and Fund 2-A now holds a total of 1,010,616 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds 89,515GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 16:42 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 201 | $13.17 | $2,647.17 |
DisclosureSEC source: 0000899243-21-022289 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,694,262 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 0 shares and Fund 2-A purchased 201 shares of the amounts shown purchased. Fund 2-A now holds a total of 1,004,747 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds 89,515GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 24, 2021 Filed May 27, 2021 15:11 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 1,278 | $13.31 | $17,010.18 |
DisclosureSEC source: 0000899243-21-020839 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,694,061 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 609 shares and 502 shares and Fund 2-A purchased 940 shares and 776 shares of the amounts shown purchased on each of 5/21/2021 and 5/24/2021, respectively. Fund 2 now holds a total of 689,515 shares of the Issuer and Fund 2-A now holds a total of 1,004,546 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds 89,515GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 21, 2021 Filed May 27, 2021 15:11 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 1,549 | $13.30 | $20,601.70 |
DisclosureSEC source: 0000899243-21-020839 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,692,783 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 609 shares and 502 shares and Fund 2-A purchased 940 shares and 776 shares of the amounts shown purchased on each of 5/21/2021 and 5/24/2021, respectively. Fund 2 now holds a total of 689,515 shares of the Issuer and Fund 2-A now holds a total of 1,004,546 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds 89,515GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 20, 2021 Filed May 20, 2021 19:01 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 8,525 | $13.30 | $113,382.50 |
DisclosureSEC source: 0000899243-21-020257 · doc4.xml · nonDerivative · entry 3 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See Footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,691,234 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,393 shares, 177 shares, and 3,350 shares and Fund 2-A purchased 2,153 shares, 273 shares, and 5,175 shares of the amounts shown purchased on each of 5/18/2021, 5/19/2021 and 5/20/2021, respectively. Fund 2 now holds a total of 688,404 shares of the Issuer and Fund 2-A now holds a total of 1,002,830 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 19, 2021 Filed May 20, 2021 19:01 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 450 | $13.44 | $6,048.00 |
DisclosureSEC source: 0000899243-21-020257 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See Footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,682,709 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,393 shares, 177 shares, and 3,350 shares and Fund 2-A purchased 2,153 shares, 273 shares, and 5,175 shares of the amounts shown purchased on each of 5/18/2021, 5/19/2021 and 5/20/2021, respectively. Fund 2 now holds a total of 688,404 shares of the Issuer and Fund 2-A now holds a total of 1,002,830 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 18, 2021 Filed May 20, 2021 19:01 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 3,546 | $13.30 | $47,161.80 |
DisclosureSEC source: 0000899243-21-020257 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See Footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,682,259 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,393 shares, 177 shares, and 3,350 shares and Fund 2-A purchased 2,153 shares, 273 shares, and 5,175 shares of the amounts shown purchased on each of 5/18/2021, 5/19/2021 and 5/20/2021, respectively. Fund 2 now holds a total of 688,404 shares of the Issuer and Fund 2-A now holds a total of 1,002,830 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 14, 2021 Filed May 18, 2021 17:06 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 5,658 | $13.08 | $74,006.64 |
DisclosureSEC source: 0000899243-21-019777 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See Footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,678,713 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 2,301 shares and Fund 2-A purchased 3,357 shares of the amount shown purchased on 5/17/2021. Fund 2 now holds a total of 683,484 shares of the Issuer and Fund 2-A now holds a total of 995,229 shares of the Issuer. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 14, 2021 Filed May 18, 2021 17:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 7,500 | $12.45 | $93,375.00 |
DisclosureSEC source: 0000899243-21-019769 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See Footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,673,055 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 3,050 shares and Fund 2-A purchased 4,450 shares of the amount shown purchased on 5/14/2021. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 13, 2021 Filed May 14, 2021 14:08 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 10,000 | $11.87 | $118,700.00 |
DisclosureSEC source: 0000899243-21-019493 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See Footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,665,555 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Fund 2 purchased 2,033 shares and 4,066 shares on 5/12/2021 and 5/13/2021, respectively, and Fund 2-A purchased 2,967 shares and 5,934 shares on 5/12/2021 and 5/13/2021, respectively. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 12, 2021 Filed May 14, 2021 14:08 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 5,000 | $12.49 | $62,450.00 |
DisclosureSEC source: 0000899243-21-019493 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See Footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,655,555 F1 · ownership.nature: Shares shown above were the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Fund 2 purchased 2,033 shares and 4,066 shares on 5/12/2021 and 5/13/2021, respectively, and Fund 2-A purchased 2,967 shares and 5,934 shares on 5/12/2021 and 5/13/2021, respectively. F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 11, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 7,500 | $12.75 | $95,625.00 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 18 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,650,555 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 10, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 7,500 | $12.93 | $96,975.00 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 17 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,643,055 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 07, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 7,500 | $13.15 | $98,625.00 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 16 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,635,555 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 06, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 6,499 | $13.15 | $85,461.85 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 15 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,628,055 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| May 05, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 7,500 | $13.28 | $99,600.00 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 14 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,621,556 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| April 28, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 200 | $13.41 | $2,682.00 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 13 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,614,056 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| April 27, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 15,000 | $13.49 | $202,350.00 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 12 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,613,856 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| April 23, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 5,000 | $13.51 | $67,550.00 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 11 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,598,856 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| April 22, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 5,000 | $13.54 | $67,700.00 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 10 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,593,856 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| April 21, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 365 | $13.59 | $4,960.35 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 9 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,588,856 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| April 20, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 4,678 | $13.54 | $63,340.12 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 8 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,588,491 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| April 19, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 625 | $13.61 | $8,506.25 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 7 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,583,813 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| April 12, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 2,893 | $13.57 | $39,258.01 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 6 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,583,188 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| April 08, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 206 | $13.67 | $2,816.02 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 5 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,580,295 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| March 26, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 37,851 | $12.88 | $487,520.88 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 4 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,580,089 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| March 25, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 5,000 | $13.11 | $65,550.00 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 3 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,542,238 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| March 24, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 2,660 | $13.94 | $37,080.40 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,537,238 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.